Zhu et al. [30] performed a meta-analysis to explore the relationship between the ERCC5/XPG Asp1104His polymorphism and cancer risk under the recessive genetic model, and found null association between the polymorphism and the risk of CRC. This evidence concerns the gene ERCC5 and colorectal carcinoma.